Ionis Pharmaceuticals (IONS) Other Non-Current Assets (2009 - 2026)

Ionis Pharmaceuticals' Other Non-Current Assets history runs 18 years deep, the most recent figure standing at $135.6 million for Q1 2026.

• On a quarterly basis, Other Non-Current Assets rose 2.83% year-over-year to $135.6 million in Q1 2026; TTM through Mar 2026 was $135.6 million, a 2.83% increase from a year earlier, with the FY2025 full-year figure at $171.6 million, up 34.83% from the prior year.
• Other Non-Current Assets eased to $135.6 million in Q1 2026 per IONS's latest filing, from $171.6 million in the prior quarter.
• Across five years, Other Non-Current Assets topped out at $171.6 million in Q4 2025 and bottomed at $58.9 million in Q2 2022.
• The 5-year median for Other Non-Current Assets is $106.0 million (2024), against an average of $108.0 million.
• Across the five-year window, Other Non-Current Assets surged 75.12% in 2023 and climbed 2.83% in 2026, its largest moves.
• Year by year, Other Non-Current Assets stood at $75.3 million in 2022, then surged by 39.73% to $105.3 million in 2023, then advanced by 20.89% to $127.3 million in 2024, then soared by 34.83% to $171.6 million in 2025, then retreated by 21.0% to $135.6 million in 2026.
• Per Business Quant, the three latest IONS Other Non-Current Assets figures stand at $135.6 million (Q1 2026), $171.6 million (Q4 2025), and $166.0 million (Q3 2025).